Tag: drugs

Study: Postoperative delirium less likely with ephedrine than phenylephrine

Editor's Note Using phenylephrine as an intraoperative vasopressor could lead to higher risk of postoperative delirium compared to ephedrine, according to findings published in the April issue of Anesthesiology. Posted online last September, these findings confirm researchers’ original hypothesis. “The treatment of intraoperative hypotension with phenylephrine may impair cerebral perfusion…

Read More

By: Matt Danford
March 20, 2024
Share

Medicare households have double the healthcare spending burden

Editor's Note The healthcare spending burden of Medicare households was double that of non-Medicare households in 2022, according to an analysis published by KFF (Kaiser Family Foundation) on March 14.  Using data from the Consumer Expenditure Survey, KFF found that average health-related expenses made up 13.6% of Medicare households’ total…

Read More

By: Brita Belli
March 19, 2024
Share

Hospital hacking threats persist amid continued chaos of Change Healthcare cyberattack

Editor's Note The ransomware group behind a recent cyberattack on one of the nation’s largest health systems has its sights set on hospitals, the FBI and the Department of Health and Human Services (HHS) warned February 27. According to a report in Chief Healthcare Executive one day later, systems were…

Read More

By: Matt Danford
March 1, 2024
Share

Study: Bariatric surgery benefits glycemic control in Type 2 diabetes patients

JAMA (healthcare publication) Network logo

Editor's Note Bariatric surgery is more effective than lifestyle and medical interventions in glycemic control for Type 2 diabetes patients, according to findings published February 27 in JAMA. The clinical trial involved four health systems and 262 participants, 96 of whom received medical- and lifestyle-focused treatment and 166 of whom…

Read More

By: Brita Belli
February 28, 2024
Share

Session: What to expect from healthcare policy, regulation in 2024

Editor's Note Since the pandemic, the view of the healthcare industry in congress has essentially gone from “hero to zero” – a shift with potentially big implications for the healthcare business leaders gathered at yesterday’s closing session from Soumi Saha, PharmD, JD, senior vice president of government affairs at Premier…

Read More

By: Matt Danford
February 8, 2024
Share

DOJ cracking down on AI tools for clinical decision-making

Editor's Note:  The U.S. Justice Department is investigating how the healthcare industry is using artificial intelligence (AI) tools to analyze and make decisions using patients’ electronic health records (EHRs), Bloomberg Law reported January 29. So far, DOJ has served subpoenas related to EHRs to at least three major pharma companies:…

Read More

By: Brita Belli
January 29, 2024
Share

Anti-inflammatory drug reduces opioid requests after surgery

Editor's Note: An FDA-approved anti-inflammatory drug used to treat poisoning and liver damage could help reduce patient requests for opioids after surgery, according to findings published October 25 in the Future Medicine journal Pain Management. The study involved 50 patients who were given either a set dose of the anti-inflammatory…

Read More

By: Brita Belli
January 16, 2024
Share

Study: Less-painful propofol alternative non-inferior in general anesthesia induction

Editor's Note: HSK3486 injectable emulsion (ciprofol) is noninferior to propofol in successful induction of general anesthesia, according toa study published December 13 in Anesthesiology. The study also confirmed prior data indicating HSK3486 causes substantially less injection-site pain. The multicenter, randomized (2:1), double-blind, propofol-controlled, phase-4 study evaluated 255 adults undergoing elective surgery…

Read More

By: Matt Danford
January 12, 2024
Share

Superpotency concerns spur recall of IV bags for vancomycin, phenylephrine, and fentanyl

Editor's Note:  Englewood, Colo,-based Leiters Health is voluntarily recalling 33 lots of vancomycin, phenylephrine, and fentanyl IV bags due to concerns that they may contain twice the labeled amount of drug, according to a January 8 safety alert from the US Food and Drug Administration (FDA). “The semi-automated IV bag…

Read More

By: Matt Danford
January 11, 2024
Share

Study models how clinicians think about managing drug-drug interactions

Editor's Note A study published in BMJ Open is “the first to present an illustrative model of clinicians’ real-world decision making for managing DDIs,” the outlet reported on December 1. DDIs, or drug-drug interactions, are known to cause significant harm (including death), hundreds of thousands of patients hospitalized each year…

Read More

By: Brita Belli
January 3, 2024
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat